EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MoMo30 Binds to SARS-CoV-2 Spike Variants and Blocks Infection by SARS-CoV-2 Pseudovirus

Kenya DeBarros iD, Mahfuz Khan iD, Morgan Coleman, Vincent C Bond iD, Virginia Floyd, Erick Gbodossou, Amad Diop, Lauren R H Krumpe, Barry R O'Keefe iD, Michael D Powell iD

Viruses · 2024

DOI: 10.3390/v16091433 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Kenya DeBarros und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Biochemistry and Immunology, Morehouse School of Medicine, 720 Westview Dr. SW, Atlanta, GA 30310, USA. Hauptthemen laut MEDLINE: Spike Glycoprotein, Coronavirus, SARS-CoV-2, Protein Binding, Antiviral Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, NIMHD NIH HHS, National Institute of Minority Health and Health Disparities (NIMHD).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

MoMo30 is an antiviral protein isolated from aqueous extracts of Momordica balsamina L. (Senegalese bitter melon). Previously, we demonstrated MoMo30’s antiviral activity against HIV-1. Here, we explore whether MoMo30 has antiviral activity against the COVID-19 virus, SARS-CoV-2. MLV particles pseudotyped with the SARS-CoV-2 Spike glycoprotein and a Luciferase reporter gene (SARS2-PsV) were developed from a three-way co-transfection of HEK293-T17 cells. MoMo30’s inhibition of SARS2-PsV infection was measured using a luciferase assay and its cytotoxicity using an XTT assay. Additionally, MoMo30’s interactions with the variants and domains of Spike were determined by ELISA. We show that MoMo30 inhibits SARS2-PsV infection. We also report evidence of the direct interaction of MoMo30 and SARS-CoV-2 Spike from WH-1, Alpha, Delta, and Omicron variants. Furthermore, MoMo30 interacts with both the S1 and S2 domains of Spike but not the receptor binding domain (RBD), suggesting that MoMo30 inhibits SARS-CoV-2 infection by inhibiting fusion of the virus and the host cell via interactions with Spike.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spike Glycoprotein, CoronavirusSARS-CoV-2Protein BindingAntiviral AgentsHumansHEK293 CellsCOVID-19Virus InternalizationViral Pseudotyping

Stichwörter der Autor:innen

COVID-19MoMo30PseudovirusSARS-CoV-2antiviralantiviral plantantiviral proteinethnopharmacologyextractfusion inhibitortraditional medicine

Substanzen

Spike Glycoprotein, Coronavirusspike protein, SARS-CoV-2Antiviral Agents

Autor:innen und Institutionen

  • Department of Microbiology, Biochemistry and Immunology, Morehouse School of Medicine, 720 Westview Dr. SW, Atlanta, GA 30310, USA.
  • Department of Community Health and Preventive Medicine, 720 Westview Dr. SW, Atlanta, GA 30310, USA.
  • PROMETRA International, Dakar-Etoile BP 6134, Senegal.
  • Malango Traditional Healers Association, Fatick BP 1763, Senegal.
  • Molecular Targets Program, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702-1201, USA.
  • Natural Products Branch, Developmental Therapeutic Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick, MD 21702, USA.

ORCID-Profile: Kenya DeBarros, Mahfuz Khan, Vincent C Bond, Barry R O'Keefe, Michael D Powell

Förderung

  • NINDS NIH HHS
  • NIMHD NIH HHS
  • National Institute of Minority Health and Health Disparities (NIMHD)
  • MSM Innovation Fund
  • Georgia Research Alliance (GRA)
  • Garden Club of America

Zitieren

APA

DeBarros, K., Khan, M., Coleman, M., Bond, V. C., Floyd, V., Gbodossou, E., Diop, A., Krumpe, L. R. H., O'Keefe, B. R., & Powell, M. D. (2024). MoMo30 Binds to SARS-CoV-2 Spike Variants and Blocks Infection by SARS-CoV-2 Pseudovirus. Viruses. https://doi.org/10.3390/v16091433

Vancouver

DeBarros K, Khan M, Coleman M, Bond VC, Floyd V, Gbodossou E, et al. MoMo30 Binds to SARS-CoV-2 Spike Variants and Blocks Infection by SARS-CoV-2 Pseudovirus. Viruses. 2024. doi:10.3390/v16091433

BibTeX
@article{DeBarros2024,
  author = {DeBarros, Kenya and Khan, Mahfuz and Coleman, Morgan and Bond, Vincent C and Floyd, Virginia and Gbodossou, Erick and Diop, Amad and Krumpe, Lauren R H and O'Keefe, Barry R and Powell, Michael D},
  title = {MoMo30 Binds to SARS-CoV-2 Spike Variants and Blocks Infection by SARS-CoV-2 Pseudovirus},
  journal = {Viruses},
  year = {2024},
  doi = {10.3390/v16091433}
}
Kostenlos starten →